BIOMAT Database Logo BIOMAT Database Logo

Neuropeptide Y (NPY) in human nasal mucosa. 1990

J N Baraniuk, and S Castellino, and J D Lundgren, and J Goff, and J Mullol, and M Merida, and J H Shelhamer, and M A Kaliner
Allergic Diseases Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.

Neuropeptide Y (NPY), a potent vasoconstrictor peptide found in sympathetic neurons, was analyzed in human inferior turbinate nasal mucosal tissue. NPY content determined by radioimmunoassay was 3.13 +/- 0.79 pmol/g tissue (n = 6) in mucosa extracted with ethanol-acetic acid. NPY-immunoreactive nerves were found around small muscular arteries, arterioles, arteriovenous anastomoses, and as free fibers near arteriolar and venous vessels. They formed a plexus around the arterial vessels, and were also present between vascular smooth muscle cells. Few NPY fibers were present near glands or the epithelium. [125I]NPY binding sites were localized by autoradiography to small muscular arteries, arterioles, and a few venous sinusoids. In explant culture experiments, 4 microM NPY did not stimulate release of [3H]glucosamine-labeled glycoconjugates or lactoferrin (a product of serous cells) from nasal mucosal fragments. Degradation of NPY by a tissue homogenate was rapid (t1/2 = 13.5 +/- 2.3 min). The degradation was inhibited by thiorphan and phosphoramidon, inhibitors of neutral endopeptidase activity. NPY released from sympathetic neurons may play a role as a constrictor of arterial vessels and regulate vasomotor tone in the human nasal mucosa.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007781 Lactoferrin An iron-binding protein that was originally characterized as a milk protein. It is widely distributed in secretory fluids and is found in the neutrophilic granules of LEUKOCYTES. The N-terminal part of lactoferrin possesses a serine protease which functions to inactivate the TYPE III SECRETION SYSTEM used by bacteria to export virulence proteins for host cell invasion. Lactotransferrin
D009297 Nasal Mucosa The mucous lining of the NASAL CAVITY, including lining of the nostril (vestibule) and the OLFACTORY MUCOSA. Nasal mucosa consists of ciliated cells, GOBLET CELLS, brush cells, small granule cells, basal cells (STEM CELLS) and glands containing both mucous and serous cells. Nasal Epithelium,Schneiderian Membrane,Epithelium, Nasal,Membrane, Schneiderian,Mucosa, Nasal
D009412 Nerve Fibers Slender processes of NEURONS, including the AXONS and their glial envelopes (MYELIN SHEATH). Nerve fibers conduct nerve impulses to and from the CENTRAL NERVOUS SYSTEM. Cerebellar Mossy Fibers,Mossy Fibers, Cerebellar,Cerebellar Mossy Fiber,Mossy Fiber, Cerebellar,Nerve Fiber
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D009478 Neuropeptide Y A 36-amino acid peptide present in many organs and in many sympathetic noradrenergic neurons. It has vasoconstrictor and natriuretic activity and regulates local blood flow, glandular secretion, and smooth muscle activity. The peptide also stimulates feeding and drinking behavior and influences secretion of pituitary hormones. Neuropeptide Y-Like Immunoreactive Peptide,Neuropeptide Tyrosine,Neuropeptide Y Like Immunoreactive Peptide,Tyrosine, Neuropeptide
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006001 Glycoconjugates Carbohydrates covalently linked to a nonsugar moiety (lipids or proteins). The major glycoconjugates are glycoproteins, glycopeptides, peptidoglycans, glycolipids, and lipopolysaccharides. (From Biochemical Nomenclature and Related Documents, 2d ed; From Principles of Biochemistry, 2d ed) Glycoconjugate

Related Publications

J N Baraniuk, and S Castellino, and J D Lundgren, and J Goff, and J Mullol, and M Merida, and J H Shelhamer, and M A Kaliner
Neuropeptide Y is a vasoconstrictor in human nasal mucosa.
November 1992, Journal of applied physiology (Bethesda, Md. : 1985),
J N Baraniuk, and S Castellino, and J D Lundgren, and J Goff, and J Mullol, and M Merida, and J H Shelhamer, and M A Kaliner
[Neuropeptide Y (NPY)].
November 2008, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
J N Baraniuk, and S Castellino, and J D Lundgren, and J Goff, and J Mullol, and M Merida, and J H Shelhamer, and M A Kaliner
Neuropeptide Y (NPY).
January 2004, Pulmonary pharmacology & therapeutics,
J N Baraniuk, and S Castellino, and J D Lundgren, and J Goff, and J Mullol, and M Merida, and J H Shelhamer, and M A Kaliner
Characterization of neuropeptide Y (NPY) receptors in human hippocampus.
July 1991, Brain research,
J N Baraniuk, and S Castellino, and J D Lundgren, and J Goff, and J Mullol, and M Merida, and J H Shelhamer, and M A Kaliner
Immunocytochemical localization of neuropeptide Y (NPY) in the human hypothalamus.
January 1984, Cell and tissue research,
J N Baraniuk, and S Castellino, and J D Lundgren, and J Goff, and J Mullol, and M Merida, and J H Shelhamer, and M A Kaliner
Neuropeptide Y (NPY) in the adrenal gland.
November 1983, Journal of the autonomic nervous system,
J N Baraniuk, and S Castellino, and J D Lundgren, and J Goff, and J Mullol, and M Merida, and J H Shelhamer, and M A Kaliner
Relevance of neuropeptide Y (NPY) in psychiatry.
January 2007, Current topics in medicinal chemistry,
J N Baraniuk, and S Castellino, and J D Lundgren, and J Goff, and J Mullol, and M Merida, and J H Shelhamer, and M A Kaliner
Neuropeptide Y (NPY) and NPY receptors in the rat pineal gland.
January 1999, Advances in experimental medicine and biology,
J N Baraniuk, and S Castellino, and J D Lundgren, and J Goff, and J Mullol, and M Merida, and J H Shelhamer, and M A Kaliner
Neuropeptide Y (NPY)-induced feeding behavior in female rats: comparison with human NPY ([Met17]NPY), NPY analog ([norLeu4]NPY) and peptide YY.
January 1987, Regulatory peptides,
J N Baraniuk, and S Castellino, and J D Lundgren, and J Goff, and J Mullol, and M Merida, and J H Shelhamer, and M A Kaliner
The cardiovascular effects of neuropeptide Y (NPY).
January 1984, Clinical and experimental hypertension. Part A, Theory and practice,
Copied contents to your clipboard!